169 related articles for article (PubMed ID: 2438337)
1. Interleukin 1 and myelin basic protein synergistically augment adoptive transfer activity of lymphocytes mediating experimental autoimmune encephalomyelitis in Lewis rats.
Mannie MD; Dinarello CA; Paterson PY
J Immunol; 1987 Jun; 138(12):4229-35. PubMed ID: 2438337
[TBL] [Abstract][Full Text] [Related]
2. Encephalitogenic and proliferative responses of Lewis rat lymphocytes distinguished by position 75- and 80-substituted peptides of myelin basic protein.
Mannie MD; Paterson PY; U'Prichard DC; Flouret G
J Immunol; 1989 Apr; 142(8):2608-16. PubMed ID: 2467932
[TBL] [Abstract][Full Text] [Related]
3. Distinct accessory cell requirements define two types of rat T cell hybridomas specific for unique determinants in the encephalitogenic 68-86 region of myelin basic protein.
Mannie MD; Paterson PY; Thomas DW; Nairn R
J Immunol; 1990 Jan; 144(2):440-50. PubMed ID: 1688579
[TBL] [Abstract][Full Text] [Related]
4. Adoptively transferred experimental autoimmune encephalomyelitis in SJL/J, PL/J, and (SJL/J x PL/J)F1 mice. Influence of I-A haplotype on encephalitogenic epitope of myelin basic protein.
McCarron R; McFarlin DE
J Immunol; 1988 Aug; 141(4):1143-9. PubMed ID: 3260919
[TBL] [Abstract][Full Text] [Related]
5. Anergy induction in encephalitogenic T cells by brain microvessel endothelial cells is inhibited by interleukin-1.
Bourdoulous S; Béraud E; Le Page C; Zamora A; Ferry A; Bernard D; Strosberg AD; Couraud PO
Eur J Immunol; 1995 May; 25(5):1176-83. PubMed ID: 7539749
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of encephalitogenic T cells confers resistance to an inhibitory anti-CD4 monoclonal antibody.
Mannie MD; Morrison-Plummer J; McConnell TJ
J Immunol; 1993 Dec; 151(12):7293-306. PubMed ID: 7505025
[TBL] [Abstract][Full Text] [Related]
7. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.
Whitacre CC; Gienapp IE; Orosz CG; Bitar DM
J Immunol; 1991 Oct; 147(7):2155-63. PubMed ID: 1717550
[TBL] [Abstract][Full Text] [Related]
8. Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease.
Welch AM; Holda JH; Swanborg RH
J Immunol; 1980 Jul; 125(1):186-9. PubMed ID: 6155396
[TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes.
Pettinelli CB; McFarlin DE
J Immunol; 1981 Oct; 127(4):1420-3. PubMed ID: 6168690
[TBL] [Abstract][Full Text] [Related]
10. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.
Lider O; Santos LM; Lee CS; Higgins PJ; Weiner HL
J Immunol; 1989 Feb; 142(3):748-52. PubMed ID: 2464023
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
Killen JA; Swanborg RH
J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
[TBL] [Abstract][Full Text] [Related]
12. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis.
Vandenbark AA; Gill T; Offner H
J Immunol; 1985 Jul; 135(1):223-8. PubMed ID: 2582032
[TBL] [Abstract][Full Text] [Related]
13. Role of macrophage-myelin basic protein interaction in the induction of experimental allergic encephalomyelitis in Lewis rats.
Carbone AM; Ovadia H; Paterson PY
J Immunol; 1983 Sep; 131(3):1263-7. PubMed ID: 6193182
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
Raziuddin S; Kibler RF; Morrison DC
J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
[TBL] [Abstract][Full Text] [Related]
15. Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism.
Vandenbark AA; Celnik B; Vainiene M; Miller SD; Offner H
J Immunol; 1995 Dec; 155(12):5861-7. PubMed ID: 7499876
[TBL] [Abstract][Full Text] [Related]
16. Activation of an encephalitogenic T lymphocyte line with a cellfree supernatant containing basic protein and I region gene products.
Vandenbark AA; Teal P; Offner H
J Immunol; 1987 Jan; 138(2):452-9. PubMed ID: 2432125
[TBL] [Abstract][Full Text] [Related]
17. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically.
Goss JA; Nakafusa Y; Roland CR; Hickey WF; Flye MW
J Immunol; 1994 Nov; 153(9):3890-8. PubMed ID: 7523508
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats.
Stepaniak JA; Gould KE; Sun D; Swanborg RH
J Immunol; 1995 Sep; 155(5):2762-9. PubMed ID: 7544385
[TBL] [Abstract][Full Text] [Related]
19. Response of rat encephalitogenic T lymphocyte lines to synthetic peptides of myelin basic protein.
Offner H; Hashim G; Vandenbark AA
J Neurosci Res; 1987; 17(4):344-8. PubMed ID: 2442405
[TBL] [Abstract][Full Text] [Related]
20. Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition.
Mannie MD; Rosser JM; White GA
J Immunol; 1995 Mar; 154(6):2642-54. PubMed ID: 7533179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
